Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394407 · ClinicalTrials.gov registry record · Phase 4
Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
NCT00394407 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 130 participants.
The verdict
NCT00394407, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
Study Summary
High blood glucose levels in hospitalized patients with diabetes are associated with increased risk of medical complications. Improved glucose control with insulin injections may improve clinical outcome and prevent some of the hospital complications. It is not known; however, what is the best insulin regimen in hospitalized patients. The use of repeated injections of regular insulin (known as sliding scale regimen) is one of the most commonly used insulin regimen for glucose control in hospitalized patients with diabetes. Recently, the combination of basal and rapid acting insulins has been shown to improve glucose control with lower rate of hypoglycemia (low blood sugar).
Interventions
- DRUG sliding scale regular insulin
- DRUG glargine basal insulin and glulisine prandial insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00394407
The ClinicalTrials.gov registry entry for NCT00394407 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sliding scale regular insulin is the first listed.
NCT00394407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00394407 about?
NCT00394407 is a clinical study titled "Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes". High blood glucose levels in hospitalized patients with diabetes are associated with increased risk of medical complications. Improved glucose control with insulin injections may improve clinical outcome and prevent some of the hospital complications. It is not known; however, what is the best insul...
What is the current status of trial NCT00394407?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2005-09. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00394407?
The interventions under investigation include: sliding scale regular insulin (DRUG), glargine basal insulin and glulisine prandial insulin (DRUG).
Who is sponsoring clinical trial NCT00394407?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.